Cancer News and Research

Latest Cancer News and Research

New device has the potential to significantly reduce sequencing of the human genome

The sequencing of the human genome was only the beginning of a much more complex task – deciphering the secrets of cellular chemistry and the mechanisms of disease. While the genome serves as a blueprint to understanding the body, proteins represent the materials that carry out these plans.

8 Jun 2005

Virulizin granted orphan drug status in Europe

Lorus Therapeutics has announced that the EMEA (European Medicines Agency) has given a positive opinion on Lorus' application for orphan drug status to Virulizin, the company's lead anticancer drug for the treatment of pancreatic cancer.

8 Jun 2005

Bone Care International issued new patent

Bone Care International has announced that the U.S. Patent and Trademark Office has issued to it U.S. Patent Number 6,903,083 entitled "Stabilized hydroxyvitamin D."

8 Jun 2005

Possible new treatment for chemobrain using the drug dexmethyphenidate (d-MPH)

Patients who take medication for cancer often find themselves with a new problem when their treatment ends.

8 Jun 2005

Omega-3 combined with propofol may lead to new drugs to treat breast cancer

Omega-3, the fatty acid found in oily fish, could be combined with a commonly used anesthetic to develop drugs to treat breast cancer, according to research published in the journal Breast Cancer Research.

8 Jun 2005

Baby born to woman following an ovary transplant from her sister

Doctors in St. Louis say a woman whose ovaries stopped working when she was a teenager, after an ovary transplant from her identical twin sister, has given birth to a baby girl.

8 Jun 2005

Breast cancer risk nothing like as bad as most women think

While no one would argue that breast cancer is a significant health threat, a new study has found that most women have an exaggerated view of their risk.

7 Jun 2005

Drinking alcohol may lower risk of developing non-Hodgkin's lymphoma

People who drink alcohol may have a lower risk of developing non-Hodgkin's lymphoma (NHL) - a type of cancer that affects the lymphatic system, suggests a study published online by The Lancet Oncology.

6 Jun 2005

New series of human drug targets available to all researchers

The Structural Genomics Consortium (SGC), an Anglo-Canadian charitable consortium of public and private agencies including Oxford University, announced recently that it has delivered its first 50 human and malaria protein structures into the public domain on budget and two months ahead of schedule.

6 Jun 2005

Statisticians learn how to analyze huge quantities of genetic data

In a conceptual breakthrough, a team of researchers led by statisticians at the Harvard School of Public Health (HSPH) has figured out how to analyze huge quantities of genetic data, surpassing the capabilities of traditional techniques and speeding the quest for understanding the genetic basis of complex diseases such as asthma and diabetes.

6 Jun 2005

5,000 people die from bowel cancer each year making it one of Australia's biggest cancer killers

Around 25 per cent, or more than 3,000 of the 13,000 bowel cancers diagnosed in Australia every year could be prevented if men and women maintained a healthy body weight, ate a healthy diet and engaged in daily physical activity.

6 Jun 2005

Boys are more reluctant than girls to swallow Jamie Oliver-style healthy school dinners

Cancer Research UK scientists found that more boys than girls, aged 4 to 16, liked fatty and sugary foods, meat, processed meat and eggs while more girls than boys liked fruit and vegetables which can help to reduce cancer risk in later life.

6 Jun 2005

Grandma was right an apple a day, if its a red one, keeps the doctor away

Scientists say there may be more truth in the old wives tale that an apple a day keeps the doctor away, than was initially credited.

6 Jun 2005

One-a-day tablet treats common infection

A bioadhesive tablet containing the antifungal drug miconazole is an effective and convenient means of treating oropharyngeal candidiasis, which is the most frequently occurring infection in head and neck cancer patients undergoing radiation therapy, scientists reported at the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary.

6 Jun 2005

Test accurately predicts aggressiveness of breast cancer

A test that measures how quickly cells are dividing is an accurate way for doctors to predict the aggressiveness of breast cancer tumors, even among women with very early stages of the disease, researchers told the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary.

6 Jun 2005

Gene linked to lower breast cancer risk

In a presentation at the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary, Dr. Uwe Langsenlehner and colleagues from Medical University Graz in Austria showed that a specific genetic variation in a cytokine gene is associated with lower breast cancer risk.

6 Jun 2005

New survey shows Americans falling short on sun protection

Over the past year, the number of Americans using sunscreen, a primary protector against skin cancer, has declined. At the same time, more Americans, including children, are being diagnosed with skin cancer than ever before.

6 Jun 2005

Study clarifies risk of recurrence for high-risk breast cancer patients

High-risk breast cancer patients do not appear to have a higher risk of relapse than the general breast cancer population during the first two years after diagnosis, unless their cancer has spread to more than 10 axillary lymph nodes, Italian researchers reported at the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary.

6 Jun 2005

Chemotherapy options improve for patients with advanced colorectal cancer

For the first time, researchers have shown that a chemotherapy regimen of capecitabine plus oxaliplatin (CAPOX) is as safe and effective as infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) in the first-line treatment of metastatic colorectal carcinoma (MCRC).

6 Jun 2005

Genetically engineered virus has shown promise as a treatment for patients with colorectal cancer

A single injection of a genetically engineered virus has shown promise as a treatment for patients with colorectal cancer that has spread to the liver, according to preliminary results reported at the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary.

6 Jun 2005